Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | June 20, 2025 08:09am

Gainers

  • Firefly Neuroscience (NASDAQ:AIFF) stock rose 19.6% to $3.59 during Friday's pre-market session. The company's market cap stands at $38.5 million.
  • Quantum BioPharma (NASDAQ:QNTM) stock moved upwards by 18.45% to $35.75. The market value of their outstanding shares is at $87.7 million.
  • Processa Pharmaceuticals (NASDAQ:PCSA) shares moved upwards by 17.97% to $0.29. The market value of their outstanding shares is at $2.8 million.
  • Vivos Therapeutics (NASDAQ:VVOS) stock moved upwards by 12.09% to $2.78. The market value of their outstanding shares is at $14.6 million.
  • Semler Scientific (NASDAQ:SMLR) shares moved upwards by 11.87% to $35.73. The company's market cap stands at $419.7 million.
  • Galmed Pharmaceuticals (NASDAQ:GLMD) shares increased by 11.79% to $1.99. The market value of their outstanding shares is at $4.0 million.

Losers

  • Regencell Bioscience (NASDAQ:RGC) shares declined by 18.4% to $51.7 during Friday's pre-market session. The market value of their outstanding shares is at $824.3 million.
  • Terns Pharma (NASDAQ:TERN) shares decreased by 16.75% to $3.33. The market value of their outstanding shares is at $349.3 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares declined by 14.24% to $4.4. The company's market cap stands at $3.4 million.
  • Co-Diagnostics (NASDAQ:CODX) stock declined by 11.66% to $0.25. The market value of their outstanding shares is at $9.4 million.
  • Insight Molecular (NASDAQ:IMDX) shares decreased by 11.4% to $2.8. The company's market cap stands at $90.3 million.
  • Opus Genetics (NASDAQ:IRD) shares fell 10.75% to $0.83. The market value of their outstanding shares is at $55.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AIFF APVO CODX GLMD IMDX IRD PCSA QNTM RGC SMLR TERN VVOS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist